SCHEMBL19996010

SCHEMBL19996010

CCOC(=O)C(C[C@@H](c1cc(F)cc(F)c1)[N+](=O)[O-])C(=O)OCC

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.37
CRHBP P24387 1/20 0.37
CRHR2 Q13324 1/20 0.37
L3MBTL1 Q9Y468 3/20 0.36
ALDH1A1 P00352 4/20 0.34
GAA P10253 2/20 0.34
KDM4E B2RXH2 2/20 0.34
FBP1 P09467 1/20 0.33
GPR174 Q9BXC1 1/20 0.33
NPC1 O15118 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.32
LMNA P02545 1/20 0.32
TSHR P16473 2/20 0.32
MEN1 O00255 2/20 0.31
KMT2A Q03164 2/20 0.31
TDP1 Q9NUW8 2/20 0.31
CYP1A2 P05177 1/20 0.31
CYP2C9 P11712 1/20 0.31
CYP2C19 P33261 1/20 0.31
CES2 O00748 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19995956 0.82 CES2 (0.36) CES2CES1
SCHEMBL2541161 0.80 MMP8 (0.46) MAPTCRHBPCRHR2L3MBTL1ALDH1A1
SCHEMBL2761707 0.78 MAPT (0.40) MAPTCRHBPCRHR2L3MBTL1ALDH1A1
SCHEMBL20520440 0.76 CES2 (0.40) MAPTL3MBTL1ALDH1A1GAASMN1; SMN2
SCHEMBL2545585 0.74 MMP8 (0.43) MAPTCRHBPCRHR2L3MBTL1ALDH1A1
SCHEMBL23455090 0.72 ALDH1A1 (0.48) MAPTCRHBPCRHR2L3MBTL1ALDH1A1
SCHEMBL21527887 0.72 ALDH1A1 (0.48) MAPTCRHBPCRHR2L3MBTL1ALDH1A1
SCHEMBL21527885 0.72 ALDH1A1 (0.48) MAPTCRHBPCRHR2L3MBTL1ALDH1A1
SCHEMBL4298042 0.72 CES2 (0.36) FBP1CES2CES1
SCHEMBL28297780 0.69 NPC1 (0.35) MAPTCRHBPCRHR2L3MBTL1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3720856-A1 DOPAMINE-& X392;-HYDROXYLASE INHIBITORS BIAL - PORTELA & Cª, S.A. (PT) 2020-10-14 EP disclosed
EP-3515917-A1 DOPAMINE-B-HYDROXYLASE INHIBITORS BIAL - PORTELA & Cª, S.A. (PT) 2019-07-31 EP disclosed
WO-2019112457-A1 DOPAMINE-Β-HYDROXYLASE INHIBITORS BIAL - PORTELA & Cª, S.A. (PT) 2019-06-13 WO disclosed
WO-2018056855-A1 DOPAMINE-B-HYDROXYLASE INHIBITORS BIAL - PORTELA & Cª, S.A. (PT) 2018-03-29 WO disclosed